MicroRNA signature and cardiovascular dysfunction

Gnanapragasam Arunachalam, Rohit Upadhyay, Hong Ding, Christopher Triggle

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The worldwide increase in the prevalence of obesity and type 2 diabetes and the associated elevated risk of cardiovascular disease (CVD) has emphasized the need to seek new therapeutic targets to offset the negative impact on human health outcomes. In this regards, microRNAs (miRNAs), a class of small noncoding RNAs that mediate posttranscriptional gene silencing, have received considerable interest. miRNAs repress gene expression by their ability to pair with target sequences in the 30 untranslated region of the messenger RNA. miRNAs play a crucial role in the biogenesis and function of the cardiovascular system and are implicated as dynamic regulators of cardiac and vascular signaling and pathophysiology. Numerous miRNAs have been identified as novel biomarkers and potential therapeutic targets for CVD. In this review, we discuss the contribution of miRNAs to the regulation of CVD, their role in macrovascular/microvascular (dys)function, their potential as important biomarkers for the early detection of CVD, and, finally, as therapeutic targets.

Original languageEnglish
Pages (from-to)419-429
Number of pages11
JournalJournal of Cardiovascular Pharmacology
Volume65
Issue number5
DOIs
Publication statusPublished - 1 May 2015

Fingerprint

MicroRNAs
Cardiovascular Diseases
Biomarkers
Untranslated Regions
Small Untranslated RNA
Cardiovascular System
RNA Interference
Type 2 Diabetes Mellitus
Blood Vessels
Early Diagnosis
Therapeutics
Obesity
Gene Expression
Messenger RNA
Health

Keywords

  • cardiovascular disease
  • diabetes
  • endothelial cells
  • endothelial dysfunction
  • endothelial progenitor cell
  • microRNA
  • vascular disease

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

MicroRNA signature and cardiovascular dysfunction. / Arunachalam, Gnanapragasam; Upadhyay, Rohit; Ding, Hong; Triggle, Christopher.

In: Journal of Cardiovascular Pharmacology, Vol. 65, No. 5, 01.05.2015, p. 419-429.

Research output: Contribution to journalArticle

Arunachalam, Gnanapragasam ; Upadhyay, Rohit ; Ding, Hong ; Triggle, Christopher. / MicroRNA signature and cardiovascular dysfunction. In: Journal of Cardiovascular Pharmacology. 2015 ; Vol. 65, No. 5. pp. 419-429.
@article{47a2ff9580e449afaaac2348c7de03b8,
title = "MicroRNA signature and cardiovascular dysfunction",
abstract = "The worldwide increase in the prevalence of obesity and type 2 diabetes and the associated elevated risk of cardiovascular disease (CVD) has emphasized the need to seek new therapeutic targets to offset the negative impact on human health outcomes. In this regards, microRNAs (miRNAs), a class of small noncoding RNAs that mediate posttranscriptional gene silencing, have received considerable interest. miRNAs repress gene expression by their ability to pair with target sequences in the 30 untranslated region of the messenger RNA. miRNAs play a crucial role in the biogenesis and function of the cardiovascular system and are implicated as dynamic regulators of cardiac and vascular signaling and pathophysiology. Numerous miRNAs have been identified as novel biomarkers and potential therapeutic targets for CVD. In this review, we discuss the contribution of miRNAs to the regulation of CVD, their role in macrovascular/microvascular (dys)function, their potential as important biomarkers for the early detection of CVD, and, finally, as therapeutic targets.",
keywords = "cardiovascular disease, diabetes, endothelial cells, endothelial dysfunction, endothelial progenitor cell, microRNA, vascular disease",
author = "Gnanapragasam Arunachalam and Rohit Upadhyay and Hong Ding and Christopher Triggle",
year = "2015",
month = "5",
day = "1",
doi = "10.1097/FJC.0000000000000178",
language = "English",
volume = "65",
pages = "419--429",
journal = "Journal of Cardiovascular Pharmacology",
issn = "0160-2446",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - MicroRNA signature and cardiovascular dysfunction

AU - Arunachalam, Gnanapragasam

AU - Upadhyay, Rohit

AU - Ding, Hong

AU - Triggle, Christopher

PY - 2015/5/1

Y1 - 2015/5/1

N2 - The worldwide increase in the prevalence of obesity and type 2 diabetes and the associated elevated risk of cardiovascular disease (CVD) has emphasized the need to seek new therapeutic targets to offset the negative impact on human health outcomes. In this regards, microRNAs (miRNAs), a class of small noncoding RNAs that mediate posttranscriptional gene silencing, have received considerable interest. miRNAs repress gene expression by their ability to pair with target sequences in the 30 untranslated region of the messenger RNA. miRNAs play a crucial role in the biogenesis and function of the cardiovascular system and are implicated as dynamic regulators of cardiac and vascular signaling and pathophysiology. Numerous miRNAs have been identified as novel biomarkers and potential therapeutic targets for CVD. In this review, we discuss the contribution of miRNAs to the regulation of CVD, their role in macrovascular/microvascular (dys)function, their potential as important biomarkers for the early detection of CVD, and, finally, as therapeutic targets.

AB - The worldwide increase in the prevalence of obesity and type 2 diabetes and the associated elevated risk of cardiovascular disease (CVD) has emphasized the need to seek new therapeutic targets to offset the negative impact on human health outcomes. In this regards, microRNAs (miRNAs), a class of small noncoding RNAs that mediate posttranscriptional gene silencing, have received considerable interest. miRNAs repress gene expression by their ability to pair with target sequences in the 30 untranslated region of the messenger RNA. miRNAs play a crucial role in the biogenesis and function of the cardiovascular system and are implicated as dynamic regulators of cardiac and vascular signaling and pathophysiology. Numerous miRNAs have been identified as novel biomarkers and potential therapeutic targets for CVD. In this review, we discuss the contribution of miRNAs to the regulation of CVD, their role in macrovascular/microvascular (dys)function, their potential as important biomarkers for the early detection of CVD, and, finally, as therapeutic targets.

KW - cardiovascular disease

KW - diabetes

KW - endothelial cells

KW - endothelial dysfunction

KW - endothelial progenitor cell

KW - microRNA

KW - vascular disease

UR - http://www.scopus.com/inward/record.url?scp=84930272738&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930272738&partnerID=8YFLogxK

U2 - 10.1097/FJC.0000000000000178

DO - 10.1097/FJC.0000000000000178

M3 - Article

VL - 65

SP - 419

EP - 429

JO - Journal of Cardiovascular Pharmacology

JF - Journal of Cardiovascular Pharmacology

SN - 0160-2446

IS - 5

ER -